1,157 results on '"Harris, Peter C."'
Search Results
52. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease
53. Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory
54. Population data improves variant interpretation in autosomal dominant polycystic kidney disease
55. Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease
56. Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease
57. SMYD3 Controls Ciliogenesis by Regulating Distinct Centrosomal Proteins and Intraflagellar Transport Trafficking.
58. 2904. Use Of Biofire® Joint Infection Filmarray for the Microbiological Diagnosis of Acute Hematogenous Septic Arthritis in Children
59. The VUS Challenge in Cystic Kidney Disease: A Case-Based Review
60. Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease
61. State of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies
62. CD8+ T cells modulate autosomal dominant polycystic kidney disease progression
63. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease
64. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease
65. Impaired Hedgehog-Gli1 Pathway Activity Underlies the Vascular Phenotype of Polycystic Kidney Disease
66. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
67. Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic
68. Recent advances in the identification and management of inherited hyperoxalurias
69. Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation
70. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease
71. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis
72. Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
73. Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies
74. B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease
75. Polycystin-2, the Protein Mutated in Autosomal Dominant Polycystic Kidney Disease (ADPKD), is a Ca 2+ -Permeable Nonselective Cation Channel
76. CD74 Promotes Cyst Growth and Renal Fibrosis in Autosomal Dominant Polycystic Kidney Disease.
77. Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease.
78. 46 - Autosomal Dominant Polycystic Kidney Disease
79. Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease
80. Progress in the understanding of polycystic kidney disease
81. Characterization of three ciliopathy pedigrees expands the phenotype associated with biallelic C2CD3 variants
82. Precision gene editing technology and applications in nephrology
83. Effect of external fixation rod coupling in computed tomography
84. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis
85. Quantitative MRI of kidneys in renal disease
86. RADIATION DOSE WITH CIRCULAR EXTERNAL FIXATION: DOES THE SURGEON GET A DOUBLE WHAMMY?
87. X-RAY BEAM GEOMETRY AS APPLIED TO CIRCULAR EXTERNAL FIXATOR IMAGING
88. Evaluation of advanced imaging biomarkers at kidney failure in patients with ADPKD: a pilot study
89. Polygenic risk affects the penetrance of monogenic kidney disease
90. Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease
91. Cloning and Characterization of a Functional Human Homolog of Escherichia coli Endonuclease III
92. Polycystin, the Polycystic Kidney Disease 1 Protein, is Expressed by Epithelial Cells in Fetal, Adult, and Polycystic Kidney
93. Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial
94. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease
95. PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease
96. Accuracy and processing time of kidney volume measurement methods in rodent polycystic kidney disease models: superiority of semi-automated kidney segmentation
97. A polycystin-centric view of cyst formation and disease: the polycystins revisited
98. Closeout of the HALT-PKD trials
99. DCDC2 Mutations Cause a Renal-Hepatic Ciliopathy by Disrupting Wnt Signaling
100. Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.